10 employees
Azelon Pharmaceuticals develops novel formulations for the treatment of osteoporosis.
2000
$4.5M
from 1 investors over 1 rounds
Azelon Pharmaceuticals raised $4.5M on October 11, 2011
Investors: Prospect Venture Partners, LP